Victoria Rashbrook
PhD, MSc, BSc(Hons)
Postdoctoral Research Scientist
I work as a postdoctoral research scientist in the Sparrow group, investigating how of different environmental factors on the development of congenital heart disease and elucidating mechanisms. My background is investigating mechanisms of cardiovascular disease with a view to develop novel therapeutics or preventative measures. In addition to heart development, I have previously worked on atherosclerosis and ischemic disease models.
Recent publications
CreER activation transiently disrupts angiogenesis by reducing proliferation and promoting apoptosis in vascular endothelial cells
Journal article
Ioannou E. et al, (2026), Angiogenesis, 29
Mutagenesis on a complex mouse genetic background by site-specific nucleases.
Journal article
Davies B. et al, (2024), Transgenic Res, 33, 415 - 426
PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
Journal article
Wood A. et al, (2023), Cardiovasc Res, 119, 599 - 610
Tamoxifen exacerbates morbidity and mortality in male mice receiving medetomidine anaesthesia.
Journal article
Rashbrook VS. et al, (2023), Anim Welf, 32
Cre toxicity in mouse models of cardiovascular physiology and disease.
Journal article
Rashbrook VS. et al, (2022), Nat Cardiovasc Res, 1, 806 - 816

